Results
63
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
63 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IBAB | €13.90 | 3.1% | 32.4% | €405.6m | €18.10 | PE51.7x | E52.0% | 1.2% | Healthcare | ||
UCB | €180.45 | -4.6% | 90.1% | €34.2b | €202.88 | PE142.6x | E28.4% | 0.8% | Pharmaceuticals & Biotech | ||
009789111 | €89.00 | 0% | 0% | €2.5b | n/a | PB0.3x | n/a | 14.2% | Banks | ||
002278082 | €2,900.00 | -3.3% | -4.6% | €145.1m | n/a | PB0.4x | n/a | 0% | Banks | ||
ARGX | €607.80 | -3.8% | 66.2% | €36.9b | €632.14 | PS20.3x | E41.8% | n/a | Pharmaceuticals & Biotech | ||
CENER | €9.45 | 1.8% | 32.5% | €2.0b | €12.39 | PE15.9x | E18.3% | 0.8% | Capital Goods | ||
BREB | €116.60 | 1.7% | 11.3% | €3.4b | €132.50 | PE12.5x | n/a | 1.1% | Diversified Financials | ||
AZE | €20.84 | 5.8% | 10.7% | €5.1b | €25.33 | PE30.1x | E14.6% | 1.1% | Capital Goods | ||
626488240 | €0.17 | 0% | -1.2% | €535.8k | n/a | PB1.5x | n/a | n/a | Diversified Financials | ||
FAGR | €19.92 | 1.8% | 11.9% | €1.5b | €22.74 | PE18.7x | E13.9% | 1.5% | Healthcare | ||
DIE | €161.80 | 1.7% | -6.4% | €8.6b | €206.67 | PE22.6x | E26.5% | 2.3% | Retail | ||
SOFT | €0.92 | -1.1% | -29.8% | €3.5m | n/a | PS4.1x | n/a | 54.3% | Real Estate Management and Development | ||
017250539 | €33.00 | 0% | -28.3% | €18.7b | n/a | PB0.8x | n/a | 15.2% | Banks | ||
TEXF | €33.40 | 0% | 2.5% | €122.5m | €44.89 | PE10.1x | n/a | 4.9% | Real Estate Management and Development | ||
CYAD | €0.41 | -4.5% | 10.1% | €17.0m | n/a | PS236.2x | n/a | n/a | Pharmaceuticals & Biotech |